CD8A and neoplasm: RESV has been shown to ameliorate tumor development by decreasing granulocytic MDSC (G‐MDSC) accumulation, impairing its suppressive ability on CD8+T cells and promoting monocytic MDSC (M‐MDSC) differentiation into CD11c+ and F4/80+ cells (84).